List of Tables
Table 1. Women’s Health Drugs Market Trends
Table 2. Women’s Health Drugs Market Drivers & Opportunity
Table 3. Women’s Health Drugs Market Challenges
Table 4. Women’s Health Drugs Market Restraints
Table 5. Global Women’s Health Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Women’s Health Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Women’s Health Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Women’s Health Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Women’s Health Drugs
Table 10. Global Women’s Health Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women’s Health Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Women’s Health Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Women’s Health Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Women’s Health Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Women’s Health Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Women’s Health Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Women’s Health Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Women’s Health Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Women’s Health Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Women’s Health Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Women’s Health Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Women’s Health Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Women’s Health Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Women’s Health Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Women’s Health Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Women’s Health Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Women’s Health Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Women’s Health Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Women’s Health Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Bayer AG Basic Information List
Table 32. Bayer AG Description and Business Overview
Table 33. Bayer AG Women’s Health Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Women’s Health Drugs Business of Bayer AG (2019-2024)
Table 35. Bayer AG Recent Developments
Table 36. Allergan Basic Information List
Table 37. Allergan Description and Business Overview
Table 38. Allergan Women’s Health Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Women’s Health Drugs Business of Allergan (2019-2024)
Table 40. Allergan Recent Developments
Table 41. Merck & Co Basic Information List
Table 42. Merck & Co Description and Business Overview
Table 43. Merck & Co Women’s Health Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Women’s Health Drugs Business of Merck & Co (2019-2024)
Table 45. Merck & Co Recent Developments
Table 46. Pfizer Inc Basic Information List
Table 47. Pfizer Inc Description and Business Overview
Table 48. Pfizer Inc Women’s Health Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Women’s Health Drugs Business of Pfizer Inc (2019-2024)
Table 50. Pfizer Inc Recent Developments
Table 51. Amgen Basic Information List
Table 52. Amgen Description and Business Overview
Table 53. Amgen Women’s Health Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Women’s Health Drugs Business of Amgen (2019-2024)
Table 55. Amgen Recent Developments
Table 56. Agile Therapeutics Inc Basic Information List
Table 57. Agile Therapeutics Inc Description and Business Overview
Table 58. Agile Therapeutics Inc Women’s Health Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Women’s Health Drugs Business of Agile Therapeutics Inc (2019-2024)
Table 60. Agile Therapeutics Inc Recent Developments
Table 61. Ferring Pharmaceuticals Basic Information List
Table 62. Ferring Pharmaceuticals Description and Business Overview
Table 63. Ferring Pharmaceuticals Women’s Health Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Women’s Health Drugs Business of Ferring Pharmaceuticals (2019-2024)
Table 65. Ferring Pharmaceuticals Recent Developments
Table 66. Mylan N.V. Basic Information List
Table 67. Mylan N.V. Description and Business Overview
Table 68. Mylan N.V. Women’s Health Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Women’s Health Drugs Business of Mylan N.V. (2019-2024)
Table 70. Mylan N.V. Recent Developments
Table 71. Lupin (India) Basic Information List
Table 72. Lupin (India) Description and Business Overview
Table 73. Lupin (India) Women’s Health Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Women’s Health Drugs Business of Lupin (India) (2019-2024)
Table 75. Lupin (India) Recent Developments
Table 76. Eli Lilly And Company Basic Information List
Table 77. Eli Lilly And Company Description and Business Overview
Table 78. Eli Lilly And Company Women’s Health Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Women’s Health Drugs Business of Eli Lilly And Company (2019-2024)
Table 80. Eli Lilly And Company Recent Developments
Table 81. Novartis AG Basic Information List
Table 82. Novartis AG Description and Business Overview
Table 83. Novartis AG Women’s Health Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Women’s Health Drugs Business of Novartis AG (2019-2024)
Table 85. Novartis AG Recent Developments
Table 86. Johnson & Johnson Basic Information List
Table 87. Johnson & Johnson Description and Business Overview
Table 88. Johnson & Johnson Women’s Health Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Women’s Health Drugs Business of Johnson & Johnson (2019-2024)
Table 90. Johnson & Johnson Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Women’s Health Drugs Downstream Customers
Table 94. Women’s Health Drugs Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Women’s Health Drugs Product Picture
Figure 2. Global Women’s Health Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Women’s Health Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Women’s Health Drugs Report Years Considered
Figure 5. Global Women’s Health Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Women’s Health Drugs Revenue in 2023
Figure 7. Women’s Health Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. EVISTA Picture
Figure 9. XGEVA Picture
Figure 10. Prolia Picture
Figure 11. Mirena Picture
Figure 12. Zometa Picture
Figure 13. Reclast/Aclasta Picture
Figure 14. Minastrin 24 Fe Picture
Figure 15. Others (Premarin, ACTONEL, ORTHO TRI-CY LO) Picture
Figure 16. Global Women’s Health Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Women’s Health Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 18. Product Picture of Hormonal Infertility
Figure 19. Product Picture of Postmenopausal Osteoporosis
Figure 20. Product Picture of Endometriosis
Figure 21. Product Picture of Contraceptives
Figure 22. Product Picture of Menopause
Figure 23. Product Picture of Polycystic Ovary Syndrome
Figure 24. Product Picture of Other Applications
Figure 25. Global Women’s Health Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Women’s Health Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 27. North America Women’s Health Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Women’s Health Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Women’s Health Drugs Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Women’s Health Drugs Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Women’s Health Drugs Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Women’s Health Drugs Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Women’s Health Drugs Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Women’s Health Drugs Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Women’s Health Drugs Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Women’s Health Drugs Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Women’s Health Drugs Sales Value (%), (2019-2030)
Figure 38. United States Women’s Health Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Women’s Health Drugs Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Women’s Health Drugs Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Women’s Health Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Women’s Health Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Women’s Health Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. China Women’s Health Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Women’s Health Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. China Women’s Health Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Women’s Health Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Women’s Health Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Women’s Health Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Women’s Health Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Women’s Health Drugs Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Women’s Health Drugs Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Women’s Health Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Women’s Health Drugs Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Women’s Health Drugs Sales Value by Application (%), 2023 VS 2030
Figure 56. India Women’s Health Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Women’s Health Drugs Sales Value by Type (%), 2023 VS 2030
Figure 58. India Women’s Health Drugs Sales Value by Application (%), 2023 VS 2030
Figure 59. Women’s Health Drugs Industrial Chain
Figure 60. Women’s Health Drugs Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
